Karin Sennfält
About
In The Last Decade
Karin Sennfält
29 papers receiving 454 citations
Peers
Comparison fields: 5 of 74
- Economics and Econometrics 123
- Pulmonary and Respiratory Medicine 95
- Nephrology 86
- Psychiatry and Mental health 80
- Epidemiology 78
Countries citing papers authored by Karin Sennfält
This map shows the geographic impact of Karin Sennfält's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Sennfält with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Sennfält more than expected).
Fields of papers citing papers by Karin Sennfält
This network shows the impact of papers produced by Karin Sennfält. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Sennfält. The network helps show where Karin Sennfält may publish in the future.
Co-authorship network of co-authors of Karin Sennfält
This figure shows the co-authorship network connecting the top 25 collaborators of Karin Sennfält. A scholar is included among the top collaborators of Karin Sennfält based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Sennfält. Karin Sennfält is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 0 | |
| 3 | 18 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | Abatacept or infliximab for patients with rheumatoid arthritis and inadequate response to methotrexate: an Italian trial-based and real-life cost-consequence analysis. | 6 |
| 7 | 5 | |
| 8 | 13 | |
| 9 | 1 | |
| 10 | 39 | |
| 11 | 34 | |
| 12 | 6 | |
| 13 | 29 | |
| 14 | 24 | |
| 15 | 14 | |
| 16 | 20 | |
| 17 | 16 | |
| 18 | 49 | |
| 19 | 19 | |
| 20 | 31 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.